Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2015 ∙ Ren, S. Newby, D. Li, S. C. Walkom, E. Miller, P. Hure, A. Attia, J.

Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ De Waure, Chiara Specchia, Maria Lucia Capizzi, Silvio Aljicevic, Mufida Dujovic, Milos Malaj, Admir Ricciardi, Walter

Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Bonner, K. Welch, E. Elder, K. Cohn, J.

Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Chaithongwongwatthana, S. Yamasmit, W. Limpongsanurak, S. Lumbiganon, P. Tolosa, J. E.

Pneumococcal vaccination during pregnancy for preventing infant infection

  • Pregnant women
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2015 ∙ Alqahtani, A. S. Rashid, H. Heywood, A. E.

Vaccinations against respiratory tract infections at Hajj

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Diphtheria
  • Tuberculosis
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Johansen, H. K. Gotzsche, P. C.

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2015 ∙ NACI

Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23)

  • Recommendation
  • Americas
  • Canada
  • Pneumococcal disease
Download:
2015 ∙ Conseil Supérieur des Maladies Infectieuses

Immunization against pneumococcal disease in high risk populations or people aged 65 years of age and older

  • Recommendation
  • Europe
  • Luxembourg
  • Pneumococcal disease
Download:
2015 ∙ JCVI

JCVI interim statement on adult pneumococcal vaccination

  • Recommendation
  • Europe
  • United Kingdom
  • Pneumococcal disease
Download:
2015 ∙ NTAGI

Minutes of the meeting of NTAGI held in 2015

  • Recommendation
  • South-East Asia
  • India
  • Pneumococcal disease
Download:
Loading...